Population-based study on the prevalence of and risk factors for human papillomavirus infection in Qujing of Yunnan province, Southwest China

Virology Journal

Volumn 9, Issue 1, 2012, Pages

  Lu Lu, Sun ^a   Qiong, Jin ^a   Hui, Li ^b   Xian Rong, Zhou ^c   Zhi Qin, Song ^d   Xue Mei, Cheng ^a   Tao, Tao ^a   Bing, Liang ^a   Lin, Xu ^e   Yu Rong, Wang ^f   Yan, Zhen ^g   Ji Wen, He ^h   Keng, Shen ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^c OBSTETRICS AND GYNECOLOGY HOSPITAL OF FUDAN UNIVERSITY   (China)

^d NAVY GENERAL HOSPITAL   (China)

^e KUNMING UNIVERSITY   (China)

^f Qujing Maternal and Child Care Service Centre   (China)

^g Vice Depart man of the National Women's Federation   (China)

^h Direct of Qujing Health Care Bureau   (China)

Author keywords

Cervix; China; Epidemiology; Genotype; Human papillomavirus

Indexed keywords

VIRUS DNA;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHINA; CLUSTER ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DNA HYBRIDIZATION; FEMALE; GENOTYPE; GROUPS BY AGE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; INFECTION RISK; INTERVIEW; MAJOR CLINICAL STUDY; MARRIED PERSON; MASS SCREENING; PAPILLOMAVIRUS INFECTION; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; WART VIRUS;

EID: 84864543090     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-153     Document Type: Article

References (34)

1. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA -A Cancer Journal for Clinicians 2005, 55:74-108.
2. Munoz N, Castellsague X, de Gonzalez AB, Gissmann L: Chapter 1: HPV in the etiology of human cancer. Vaccine 2006, 24(Suppl 3):1-10.
3. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Journal of Pathology 1999, 189:12-19.
4. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R: Clifford GM Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 2007, 121:621-632.
5. Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, Ronco G, de Sanjose S, Shin HR, Sukvirach S, Thomas JO, Tunsakul S, Meijer CJ, Franceschi S: Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005, 366:991-998.
6. Li Y, Wang Y, Jia C, Ma Y, Lan Y, Wang S: Detection of human papillomavirus genotypes with liquid bead microarray in cervical lesions of northern Chinese patients. Cancer Genet Cytogenet 2008, 182:12-17.
7. Zhao R, Zhang WY, Wu MH, Zhang SW, Pan J, Zhu L, Zhang YP, Li H, Gu YS, Liu XZ: Human papillomavirus infection in Beijing, People's Republic of China: a population-based study. Br J Cancer 2009, 101:1635-1640.
8. Jin Q, Shen K, Li H, Zhou XR, Huang HF, LENG JH: Age-specific prevalence of human papillomavirus by grade of cervical cytology in Tibetan women. Chin Med J 2010, 123:2004-2011.
9. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM: Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 1989, 7:209-214.
10. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim- Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V: A review of human carcinogens-Part B: biological agents. Lancet Oncol 2009, 10:321-322.
11. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H: Classification of papillomaviruses. Virology 2004, 324:17-27.
12. Dai M, Bao YP, Li N, Clifford GM, Vaccarella S, Snijders PJ, Huang RD, Sun LX, Meijer CJ, Qiao YL, Franceschi S: Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. Br J Cancer 2006, 95:96-101.
13. Li LK, Dai M, Clifford GM, Yao WQ, Arslan A, Li N, Shi JF, Snijders PJ, Meijer CJ, Qiao YL, Franceschi S: Human papillomavirus infection in Shenyang City, People's Republic of China: A population-based study. Br J Cancer 2006, 95:1593-1597.
14. Ye J, Cheng X, Chen X, Ye F, Lü W, Xie X: Prevalence and risk profile of cervical human papillomavirus infection in Zhejiang Province, southeast China: a population-based study. Virology Journal 2010, 7:66.
15. Wu RF, Dai M, Qiao YL, Clifford GM, Liu ZH, Arslan A, Li N, Shi JF, Snijders PJ, Meijer CJ, Franceschi S: Human papillomavirus infection in women in Shenzhen City, People's Republic of China, a population typical of recent Chinese urbanization. Int J Cancer 2007, 121:1306-1311.
16. Tsao KC, Huang CG, Kuo YB, Chang TC, Sun CF, Chang CA, Yang SL, Chan EC: Prevalence of Human Papillomavirus Genotypes in Northern Taiwanese Women. J Med Virol 2010, 82:1739-1745.
17. Bao YP, Li N, Smith JS, Qiao YL: Human papillomavirus type distribution in women from Asia: a meta-analysis. Int J Gynecol Cancer 2008, 18:71-79.
18. Deacon JM, Evans CD, Yule R, Desai M, Binns W, Taylor C, Peto J: Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort. Br J Cancer 2000, 83:1565-1572.
19. Moscicki AB, Hills N, Shiboski S, Powell K, Jay N, Hanson E, Miller S, Clayton L, Farhat S, Broering J, Darragh T, Palefsky J: Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. Jama 2001, 285:2995-3002.
20. La Vecchia C, Franceschi S, Decarli A, Fasoli M, Gentile A, Parazzini F, Regallo M: Sexual factors, venereal diseases, and the risk of intraepithelial and invasive cervical neoplasia. Cancer 1986, 58:935-941.
21. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA: Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003, 157:218-226.
22. Chan PK, Ho WC, Wong MC, Chang AR, Chor JS, Yu MY: Epidemiologic risk profile of infection with different groups of human papillomaviruses. J Med Virol 2009, 81:1635-1644.
23. Brown DR, Shew ML, Qadadri B, Neptune N, Vargas M, Tu W, Juliar BE, Breen TE, Fortenberry JD: A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis 2005, 191:182-192.
24. Goodman MT, Shvetsov YB, McDuffie K, Wilkens LR, Zhu X, Thompson PJ, Ning L, Killeen J, Kamemoto L, Hernandez BY: Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study. Cancer Res 2008, 68:8813-8824.
25. Winer RL, Feng Q, Hughes JP, O'Reilly S, Kiviat NB, Koutsky LA: Risk of female human papillomavirus acquisition associated with first male sex partner. J Infect Dis 2008, 197:279-282.
26. Moscicki AB, Shiboski S, Broering J, Powell K, Clayton L, Jay N, Darragh TM, Brescia R, Kanowitz S, Miller SB, Stone J, Hanson E, Palefsky J: The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998, 132:277-284.
27. Sherman ME, Schiffman M, Cox JT: Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS). J Natl Cancer Inst 2002, 94:102-107.
28. Althoff KN, Paul P, Burke AE, Viscidi R, Sangaramoorthy M, Gravitt PE: Correlates of cervicovaginal human papillomavirus detection in perimenopausal women. J Womens Health (Larchmt) 2009, 18:1341-1346.
29. Jacobs MV, Walboomers JM, Snijders PJ, Voorhorst FJ, Verheijen RH, Fransen- Daalmeijer N, Meijer CJ: Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer 2000, 87:221-227.
30. Castle PE, Schiffman M, Herrero R, Hildesheim A, Rodriguez AC, Bratti MC, Sherman ME, Wacholder S, Tarone R, Burk RD: A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis 2005, 191:1808-1816.
31. Franco EL, Villa LL, Sobrinho JP, Prado JM, Rousseau MC, Desy M, Rohan TE: Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 1999, 180:1415-1143.
32. Lin H, Ma YY, Moh JS, Ou YC, Shen SY, ChangChien CC: High prevalence of genital human papillomavirus type 52 and 58 infection in women attending gynecologic practitioners in South Taiwan. Gynecol Oncol 2006, 101:40-45.
33. Herrero R, Castle PE, Schiffman M, Bratti MC, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Chen S, Rodriguez AC, Burk RD: Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 2005, 191:1796-1807.
34. An HJ, Cho NH, Lee SY, Kim IH, Lee C, Kim SJ, Mun MS, Kim SH, Jeong JK: Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer 2003, 97:1672-1680.